TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | 1 | 0 | -9 | -15 | -20 | -7 |
| S | %wins | 67 | 67 | 33 | 67 | 67 | 67 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/17 12:16 | 12/11/17 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dreismann Heinrich | UT | D | S | -201 | 33.50 | 0 | -6 | -15 | 34 | D | |||||||||||||||
11/5/15 18:14 | 11/5/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dreismann Heinrich | UT | D | S.d | -2,666 | 44.44 | 33 | -60 | -86 | 10 | D | 82 | 25 | 41 | 46 | 17 | 18 | 11 | 14 | -1 | -1 | -3 | -18 | -22 | -61 | |
2/20/14 17:27 | 2/18/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dreismann Heinrich | UT | D | S.d | -1,050 | 35.00 | 33 | -30 | -100 | 0 | D | 47 | 40 | 27 | 30 | 64 | 25 | 7 | 12 | 3 | 3 | 1 | 1 | 3 | -7 | |
5/10/13 17:06 | 5/10/13 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dreismann Heinrich | UT | D | S.d | -935 | 31.16 | 33 | -30 | -100 | 0 | D | 34 | 17 | -1 | 17 | 20 | 7 | 9 | 8 | 0 | 0 | 3 | -10 | -25 | 9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |